Trials / Conditions / Periampullary Adenocarcinoma

Periampullary Adenocarcinoma

9 registered clinical trials studyying Periampullary Adenocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas NCT05788029	Tongji Hospital	N/A
Completed	Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer NCT03724994	Lund University	—
Recruiting	High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer Tha NCT02757859	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	N/A
Completed	Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma NCT01781728	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Terminated	Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers NCT01229111	National Cancer Institute (NCI)	Phase 2
Unknown	SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer NCT01811277	Peking University	Phase 2
Completed	Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary NCT00987766	Vanderbilt-Ingram Cancer Center	Phase 1
Completed	Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer NCT00983268	Vanderbilt-Ingram Cancer Center	Phase 1
Terminated	Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers NCT00832637	New Mexico Cancer Research Alliance	Phase 2